Cash on Hand for Bristol-Myers Squibb (BMY)
According to Bristol-Myers Squibb's latest reported financial statements, the company's latest reported cash and short-term investments is $10.67B USD. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for a net cash/debt picture and with total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingCash on HandSwitch metric
Latest period
$10.67B
YoY change
-1.7%
5Y CAGR
-8.3%
Peak year (2021)
$17.22B
Latest annual
$10.67B
Cash on Hand history chart for Bristol-Myers Squibb (BMY) from 1987 to 2025
Cash on Hand history table for Bristol-Myers Squibb (BMY) from 1987 to 2025
| Fiscal year | Period ended | Reported | Cash on Hand | YoY |
|---|---|---|---|---|
| 2025 | $10.67B | -1.7% | ||
| 2024 | $10.86B | -11.6% | ||
| 2023 | $12.28B | +32.7% | ||
| 2022 | $9.25B | -46.3% | ||
| 2021 | $17.22B | +4.7% | ||
| 2020 | $16.45B | +6.9% | ||
| 2019 | $15.39B | +75.7% | ||
| 2018 | $8.76B | +28.6% | ||
| 2017 | $6.81B | +7.3% | ||
| 2016 | $6.35B | +48.7% | ||
| 2015 | $4.27B | -42.6% | ||
| 2014 | $7.43B | +64.3% | ||
| 2013 | $4.53B | +60.0% | ||
| 2012 | $2.83B | -67.6% | ||
| 2011 | $8.73B | +19.6% | ||
| 2010 | $7.30B | -14.2% | ||
| 2009 | $8.51B | +3.0% | ||
| 2008 | $8.27B | +271.5% | ||
| 2007 | $2.23B | -44.6% | ||
| 2006 | $4.01B | -30.8% | ||
| 2005 | $5.80B | -22.4% | ||
| 2004 | $7.47B | +34.4% | ||
| 2003 | $5.56B | +39.4% | ||
| 2002 | $3.99B | -29.4% | ||
| 2001 | $5.65B | +67.0% | ||
| 2000 | $3.38B | +14.5% | ||
| 1999 | $2.96B | +31.8% | ||
| 1998 | $2.24B | +54.1% | ||
| 1997 | $1.46B | -13.4% | ||
| 1996 | $1.68B | +2.2% | ||
| 1995 | $1.65B | +0.2% | ||
| 1994 | $1.64B | -32.2% | ||
| 1993 | $2.42B | +13.3% | ||
| 1992 | $2.14B | +48.9% | ||
| 1991 | $1.44B | +140.8% | ||
| 1990 | $596.00M | +16.9% | ||
| 1989 | $510.00M | -79.7% | ||
| 1988 | $2.51B | +7.0% | ||
| 1987 | $2.35B | — |
Cash on Hand values are taken from Bristol-Myers Squibb's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Bristol-Myers Squibb (BMY) cash and short-term investments totalled $10.67B – edged down 1.7% year-over-year.
Bristol-Myers Squibb cash and short-term investments has contracted on net over the period, with a -8.3% compound annual growth rate over 2020–2025 (5 years).
Between 2021 and 2025, Bristol-Myers Squibb cash and short-term investments plunged 38.0%, falling from $17.22B to $10.67B.
2021 marks the peak cash and short-term investments at $17.22B, with the historical low of $510.00M recorded in 1989.
Bristol-Myers Squibb (BMY) sits 5th of 8 Healthcare peers we track on this metric, against a peer median of $11.85B.
Bristol-Myers Squibb Cash on Hand by Year
Bristol-Myers Squibb Cash on Hand 2025: $10.67B
Bristol-Myers Squibb cash and short-term investments in 2025 was $10.67B, edged down 1.7% below 2024.
Bristol-Myers Squibb Cash on Hand 2024: $10.86B
Bristol-Myers Squibb cash and short-term investments in 2024 was $10.86B, declined 11.6% below 2023.
Bristol-Myers Squibb Cash on Hand 2023: $12.28B
Bristol-Myers Squibb cash and short-term investments in 2023 was $12.28B, surged 32.7% from 2022.
Bristol-Myers Squibb Cash on Hand 2022: $9.25B
Bristol-Myers Squibb cash and short-term investments in 2022 was $9.25B, plunged 46.3% below 2021.
Bristol-Myers Squibb Cash on Hand 2021: $17.22B
Bristol-Myers Squibb cash and short-term investments in 2021 was $17.22B.
See more financial history for Bristol-Myers Squibb (BMY).
Sector peers — Cash on Hand
Companies in the same sector as Bristol-Myers Squibb, ranked by their latest cash and short-term investments.
| Company | Cash on Hand | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $28.12B | Healthcare |
| Novo Nordisk A/S (NVO) | $26.96B | Healthcare |
| Johnson & Johnson (JNJ) | $20.10B | Healthcare |
| Merck & Co., Inc. (MRK) | $14.56B | Healthcare |
| Amgen Inc. (AMGN) | $9.13B | Healthcare |
| Eli Lilly and Company (LLY) | $7.27B | Healthcare |
| AstraZeneca PLC (AZN) | $5.74B | Healthcare |
| AbbVie Inc. (ABBV) | $5.26B | Healthcare |
Frequently asked questions
What is Bristol-Myers Squibb's cash and short-term investments?
- Latest reported cash and short-term investments for Bristol-Myers Squibb (BMY) is $10.67B (period ending December 31, 2025).
How has Bristol-Myers Squibb cash and short-term investments changed year-over-year?
- Bristol-Myers Squibb (BMY) cash and short-term investments changed -1.7% year-over-year on the latest annual filing.
What is the long-term growth rate of Bristol-Myers Squibb cash and short-term investments?
- Bristol-Myers Squibb (BMY) cash and short-term investments compound annual growth rate is -8.3% over the most recent 5 years available.
When did Bristol-Myers Squibb cash and short-term investments hit its highest annual value?
- Bristol-Myers Squibb cash and short-term investments reached its highest annual value of $17.22B in 2021.
What was Bristol-Myers Squibb cash and short-term investments in 2024?
- Bristol-Myers Squibb (BMY) cash and short-term investments in 2024 was $10.86B.
What was Bristol-Myers Squibb cash and short-term investments in 2025?
- Bristol-Myers Squibb (BMY) cash and short-term investments in 2025 was $10.67B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BMY Overview
Company profile, financial tools, and key metrics
BMY Revenue Counter
Earns $1,528 every second. See per minute, hour, and day.
BMY Earnings Counter
Earns $223.65 per second net profit. See per minute, hour, and day.
BMY Economic Scale
Exceeds Bahrain's GDP. Compare with world economies.
BMY What If Invested
What if you had invested $1,000? See historical returns from any date.
BMY How It Makes Money
Discover visual breakdown of $48.19B in revenue — where it comes from and where it goes.
BMY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BMY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BMY Daily Price Character
Steady · 47.3% historical win rate (green days). Streaks & record days.
BMY Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BMY Stock Split History
6 splits on record. Dates, ratios, and cumulative multiple.
BMY Dividend Profile
Yield: 4.34%. Safety: 7/8. See full history.
BMY Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
BMY Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.